From smallpox to polio and beyond: disease surveillance in India. by Heymann, David L
Indian J Med Res 120, August 2004, pp 70-72
Commentary
From smallpox to polio and beyond:  disease surveillance in India
The foundation of India’s highly successful smallpox
eradication programme was active disease surveillance-
the search for smallpox in communities and households,
at markets and at religious festivities by networks of
community level health workers1 .  By identification and
isolation of  persons with smallpox and vaccination of
their known contacts including persons living in close
proximity, India interrupted endogenous transmission of
smallpox in the mid-1970s.  The success of smallpox
eradication in India provides an example of the power
of simplified infectious disease surveillance in detecting
the target disease and facilitating an appropriate response.
Smallpox also provides a striking example of the
complex interaction of infectious diseases, and a
justification for sustainable multi-disease surveillance
mechanisms.  As smallpox eradication was being
certified worldwide in 1980, a new and unknown
infectious disease was silently spreading around the
world, eluding routine disease surveillance in most
countries in which it was present.  In 1981 this new
disease was finally identified as acquired immune
deficiency syndrome (AIDS), and by 1984 AIDS and
smallpox had been shown to be linked in a manner that
unexpectedly impacts on smallpox vaccine safety.
During that year, a human immunodeficiency virus
(HIV)- infected military recruit in the United States who
was vaccinated against smallpox developed generalized
vaccinia and died, demonstrating the fatal potential of
smallpox vaccine in HIV infected persons2 .  This silent
interaction between the vaccinia virus of smallpox
vaccine and HIV was detected by multi-disease
surveillance for clinical disease, supported by public
health laboratory capacity.  The fatal interaction between
vaccinia and HIV remains an obstacle to the use of
smallpox vaccine, should it ever become necessary in
the world.
As we enter the 21st century, the microbial world
remains complex, dynamic, and constantly evolving.
Microbes reproduce rapidly, mutate frequently, and adapt
with relative ease to new environments and hosts.
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Vaccines effective one year for diseases such as
meningococcal meningitis or influenza may no longer be
effective the next year because of the appearance of
new epidemic strains or drifts in genetic sequences3 .
Microbes are likewise quick to exploit new opportunities
to spread, adapt, and resist.
Microbes that infect humans can result in infectious
diseases that are endemic and kill or disfigure; or they
can cause epidemics that appear suddenly and spread
from human to human with ease 4 . Microbes also develop
resistance to the drugs used to treat them, decreasing
the effectiveness of standard treatment regimes; and
they can have a negative interaction as in the case of
tuberculosis and HIV where in some parts of the world,
including parts of India, HIV is driving the numbers of
active pulmonary tuberculosis higher than ever before5 ,6 .
For all of these reasons, it is important and necessary
to keep the microbial world at bay through reliable multi-
disease surveillance systems that detect infectious
diseases, and through health systems that provide an
appropriate response.  Failure to identify human
populations at risk for endemic diseases such as AIDS
could, for example, result in AIDS prevention messages
that are aimed at persons who are not at risk of HIV
infection while missing those who are7 .  Failure to detect
when diseases such as malaria are not cured by usual
anti-malarials can result in continued use of anti-malarials
to which resistance has developed, with an increase in
malaria-related mortality8 .  And delayed detection of an
epidemic of disease such as severe acute respiratory
syndrome (SARS) can result in local or international
spread with human suffering and death, and the risk of
reversible but costly disruption of trade and travel9 .
Jacob John and his co-authors describe10, a model
for disease surveillance that was shown to be applicable
in the Kottayam District of Kerala State, and that was
then successfully applied throughout the state.  The
system in Kerala State is comprehensive and sustainable,
encompassing both private and public sector medical
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facilities.  Throughout its first year of operation it has
identified a newly emerging infectious disease epidemic
of significant importance (leptospirosis), an unexpected
risk population for a high mortality endemic infectious
disease (measles) and a recurrent epidemic prone
infection (cholera).  Once these disease patterns were
identified, clinical and public health measures were
instituted permitting more effective control.
John and his co-authors emphasize two important
objectives of surveillance systems: monitoring the success
of ongoing interventions, and the detection and
interception of outbreaks.  At the same time, they
underscore the importance of including both public and
private health facilities in such a system, and the
importance of its sustainability.  By using standardized
case definitions and a no cost mail-in system, the chances
for standardized, uniform sustained reporting have been
increased.  By short-course training of medical personnel
while they continued to perform their usual functions,
and by not placing new contractual staff for surveillance
alone, even greater chances of sustainability have been
ensured.
Finally, John and his co-authors emphasize that
surveillance systems depend on public health laboratories
with a variety of reliable diagnostic capacities, and
epidemiological services that can use the surveillance
information to respond.  They further point out that these
are the weak links in the surveillance system in Kerala
State.
Indeed, public health laboratory and epidemiological
capacity are the weak links in surveillance in many other
parts of the world as well.  Laboratory diagnostic capacity
is often not available to confirm the diagnosis of
infectious diseases in clinical settings, let alone for
confirmation of diagnosis in surveillance systems.
Stronger and increased numbers of public health
laboratories that use standard and quality controlled
diagnostic procedures are required.  In addition to helping
better understand clinically evident infections as in the
system in Kerala State, such laboratories can add a new
capacity to surveillance: better understanding of the silent
interplay between infectious organisms and their hosts.
Reliably conducted serological tests and isolation
techniques allow the detection of persons with evidence
of previous infection, persons with asymptomatic
infections or persons who serve as healthy carriers of
the infectious agent.  Added to this, molecular biology
capabilities provide a precise tool for strain
characterization, and epidemiological tracking of different
strains can help understand whether different endemic
diseases or outbreaks are linked or independent, or if
what appears to be a pandemic is in fact a juxtaposition
of independent epidemics.
Nowhere is the usefulness of molecular biology more
evident than in India’s surveillance system for acute
flaccid paralysis, a part of the national polio eradication
programme.    Each poliovirus isolate from children with
acute flaccid paralysis undergoes meticulous molecular
study at the Enterovirus Research Centre (ICMR) in
Mumbai.  Polioviruses studied at the Centre do not only
come from children with acute flaccid paralysis however;
they also come from sampling of the environment in
Mumbai11.  By genomic sequencing of each poliovirus
isolated, a clear understanding of the geographical origin
of that virus is obtained12.  Such “molecular mapping”
permits targeting of polio containment activities at the
geographic source of wild poliovirus, speeding the way
to interruption of wild poliovirus transmission.  The utility
and importance of such laboratory support to surveillance
for acute flaccid paralysis is clearly noted this year in
monitoring the impact of India’s polio eradication
activities:  between 1 January and 13 July 2004 India
has reported only 18 children with acute flaccid paralysis
due to infection with the wild poliovirus compared to 87
children during the same period in 2003, and to a total of
1600 children with flaccid paralysis during the year 2002
(WHO, South East Asia Regional Office).
Surveillance systems in India have evolved greatly
since the 1970s when such systems used to eradicate
smallpox consisted of no more than a web of village and
district level workers who actively sought out those with
clinical manifestations of smallpox.  Today India has
developed sustainable and all-encompassing multi-
disease surveillance in Kerala State, where regular
information about the occurrence of infectious diseases
is available for monitoring the impact of disease control
and detection of epidemic diseases as they emerge or
re-emerge.  What is more, India has also developed high
technology laboratory support for surveillance of acute
flaccid paralysis at the Enterovirus Research Centre in
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Mumbai.The power of India’s multi-disease surveillance
activities can and will be increased by the application of public
health laboratory support to sustainable state level multi-
disease surveillance.  Further application of genetic
sequencing and other high technology procedures will greatly
amplify this power; while the application of the fruits of India’s
IT revolution will ensure timely electronic reporting, rapid
communication between laboratory and epidemiology
workers, and a means of geographical mapping of disease
patterns to the most peripheral level of the health system.
The tools for more powerful multi-disease surveillance in
India are present and the surveillance system described by
John and his co-authors is at its base. The future for disease
surveillance in India is bright.
David L. Heymann
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